Literature DB >> 9005893

Assessment of ischemia and reperfusion injury.

J R Urbaniak1, A V Seaber, L E Chen.   

Abstract

Direct videomicroscopy of the rat cremaster muscle microcirculation supplemented by animal models of replantation, vascular crushing, and muscle function after injury and recovery were used to investigate the occurrence of reperfusion failure. It is evident that failure of blood reflow may be induced by multiple factors that can be grouped into categories of ischemia, intimal damage, and systemic or local responses, which are referred to as the no reflow triad. The components comprising the 3 sides of the no reflow triad can interact with one another in an intricate manner, and any single factor or combination of factors is capable of triggering the events leading to reperfusion failure. The pronounced regional nature of reperfusion injury and the direct relationship between the severity of the observed vascular alterations and increasing duration of ischemia have been documented. The dynamic changes and histopathology of the microcirculation included constriction of the arteries, swelling of endothelial and leukocytes, and erythrocyte rouleaux formation during ischemia. As ischemia duration was lengthened, the degree of these changes increased correspondingly. The changes on reperfusion were disruption of blood flow patterns, vortex formation, regional stasis, adhesion and migration of leukocytes, focal hemorrhage, edema, vasospasm, and platelet aggregation. The deleterious effects of systemic acidosis, interstitial hemorrhage, denervation, and prolonged venous occlusion were subsequently documented. The application of information gained from this series of laboratory experiments has resulted in continued improvement in the success rate in clinical microvascular surgery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9005893

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  7 in total

1.  Vascular anatomy of the hamster retractor muscle with regard to its microvascular transfer.

Authors:  M C J de With; A M de Vries; A B A Kroese; E P A B van der Heijden; R L A W Bleys; S S Segal; M Kon
Journal:  Eur Surg Res       Date:  2008-12-16       Impact factor: 1.745

2.  Pattern of presentation of pressure ulcers in traumatic spinal cord injured patients in University College Hospital, Ibadan.

Authors:  Ayodele O Iyun; Adefolarin O Malomo; Odunayo M Oluwatosin; Samuel Adesina Ademola; Matthew T Shokunbi
Journal:  Int Wound J       Date:  2011-10-28       Impact factor: 3.315

3.  Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation: a preliminary study.

Authors:  Z-B Sun; J-W Wang; H Xiao; Q-S Zhang; W-S Kan; F-B Mo; S Hu; S-N Ye
Journal:  Osteoporos Int       Date:  2014-08-12       Impact factor: 4.507

Review 4.  A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology.

Authors:  Terence J Coderre; Gary J Bennett
Journal:  Pain Med       Date:  2010-08       Impact factor: 3.750

5.  ABCB1 gene polymorphisms and glucocorticoid-induced avascular necrosis of the femoral head susceptibility: a meta-analysis.

Authors:  Zhigang Li; Dewei Zhao; Benjie Wang
Journal:  Med Sci Monit       Date:  2014-12-29

6.  Association between genetic polymorphisms of MMP8 and the risk of steroid-induced osteonecrosis of the femoral head in the population of northern China.

Authors:  Jieli Du; Tianbo Jin; Yuju Cao; Junyu Chen; Yongchang Guo; Mingqi Sun; Jian Li; Xiyang Zhang; Guoqiang Wang; Jianzhong Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Cyclic Polypeptide D7 Protects Bone Marrow Mesenchymal Cells and Promotes Chondrogenesis during Osteonecrosis of the Femoral Head via Growth Differentiation Factor 15-Mediated Redox Signaling.

Authors:  Jiazheng Chen; Zichen Cui; Yi Wang; Linmao Lyu; Changgong Feng; Dianjie Feng; Yifan Cheng; Ziqing Li; Shui Sun
Journal:  Oxid Med Cell Longev       Date:  2022-03-03       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.